Today on DrugResearcher.com   Did Pfizer overpay in Icagen deal? Amgen admits job cuts on way after anaemia drugs debacle Agilent expands microarray offering with FFPE sample labelling kit Blockbuster potential for Actelion insomnia drug No lack of innovation in pharma, says Wyeth

Related Industry News   Pfizer pipped to the post by biologics plant announcement eClinical big players struggle Genzyme shells out $64m to quash lawsuit US-Russian CRO pact inked

Breaking News on Drug Discovery
Daily  Thursday 16 August 2007		Forward to a colleague

	Product Overview Innovative New Shaking Incubator from Stuart® A compact bench top incubator can be just enough for bacterial cell culturing. The latest shaking incubator from Stuart® is packed with novel features such as BioCote antimicrobial protection:... Click Here Access Full Stories Did Pfizer overpay in Icagen deal? Pfizer has penned a discovery-stage deal with Icagen aimed at finding potential pain alleviating drugs, but has forked out over twice the industry average... Read Amgen admits job cuts on way after anaemia drugs debacle Amgen has finally put an end to weeks of rumours and speculations by admitting its plans to slash 12-14 per cent of its workforce to offset the recent difficulties it has been facing with the sales of its anaemia... Read Agilent expands microarray offering with FFPE sample labelling kit Using technology recently licensed from Kreatech, Agilent has launched a kit to enable researchers to more easily access genetic information from formalin-fixed paraffin embedded (FFPE) samples... Read Blockbuster potential for Actelion insomnia drug Analysts are waiting with baited breath for the latest clinical data on Actelion's first-in-class insomnia drug, pointing to its blockbuster potential and deriding current insomnia drugs as 'shockingly limited'... Read No lack of innovation in pharma, says Wyeth The often cited decline in R&D productivity and dwindling innovation within the pharma industry is actually a thing of the past, according to Wyeth's head of business development... Read
	All News Headlines for: August | July | June
	Product Overview A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here
	Related Industry News Pfizer pipped to the post by biologics plant announcement Pfizer was taken by surprise this week as a US engineering firm announced that it had been awarded a contract to manage construction of the firm's proposed biotech production plant in Ireland, before the plant... Read eClinical big players struggle etrials and Clinphone, two big players in the eclinical industry are struggling to keep their heads above water as both companies' recent woes have impacted their bottom line... Read Genzyme shells out $64m to quash lawsuit Genzyme's pocket is $64m (€47m) lighter after the top ten biopharma firm agreed to shell out the cash to settle a legal dispute... Read US-Russian CRO pact inked Russian contract research organisation (CRO) Synergy Research Group has hooked up with a US-based CRO in a bid to expand its services to North America... Read Weekly comment Speculation on gene therapy trial death 'premature' Targeted Genetics said it was 'premature as well as irresponsible' to draw any conclusions on what caused the death of a patient who participated in a clinical trial testing the safety of the firm's new gene therapy. Read Product Literature Advanced microarray printing for protein applications - Free Download Arrayjet Ltd have developed a high quality, flexible and fast inkjet printing system and applied it to production of protein microarrays. Print proteomic and genomic microarrays with confidence using Arrayjet technology... Click Here Previous Headlines DNA vaccine for MS passes Phase I A new DNA vaccine has passed a Phase I trial in patients with multiple sclerosis (MS) and is set to enter the next development stage, according to researchers... Read Antibody rival drawing investors to Molecular Partners An award-winning therapeutic protein technology, touted as superior to antibodies, has attracted venture capitalist investment for its owners, the Swiss biotech Molecular Partners... Read First 3D images of living cell a 'dream' A US scientist says he has fulfilled his dream by creating the first 3D images of a living cell, finally allowing researchers to study them in their natural state... Read Big pharma's wish list Some of the world's largest pharma firms have set out what therapeutic areas and specific mechanisms are becoming more important to them, and which will be left by the wayside... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving GVK Biosciences, Lab Research, GATC Biotech and Bridge Pharmaceuticals... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com